NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 80mg + Ezetimibe IP 10mg for M/s Pure and Cure Healthcare Pvt. Ltd (Manufacturer) & M/s Eris Lifesciences Ltd. (Marketer)

Nov 14, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 13, 2025, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 80mg + Ezetimibe IP 10mg for M/s Pure and Cure Healthcare Pvt. Ltd (Manufacturer) & M/s Eris Lifesciences Ltd. (Marketer).

The following has been stated: -

•Each Film Coated Tablet Contains: Atorvastatin Calcium IP Eq. to Atorvastatin 80mg + Ezetimibe IP 10mg for M/s Pure and Cure Healthcare Pvt. Ltd (Manufacturer) & M/s Eris Lifesciences Ltd. (Marketer), the retail price is 36.12 (Rs)

[Notification No.:19(4900)/2025/DP/NPPA/Div.III/12447/2025]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT